Abstract
We present a new class of molecular specific contrast agents for optical imaging of carcinogenesis in vivo - gold nanoparticles conjugated with monoclonal antibodies specific for cancer biomarkers. The nanoparticles can resonantly scatter visible light that provides an opportunity for optical interrogation using reflectance spectroscopic and imaging modalities.
© 2004 Optical Society of America
PDF ArticleMore Like This
Jesse Aaron, Tom Collier, Vivian Mack, Rebecca Richards-Kortum, Lezlee Coghlan, Michele Follen, and Konstantin Sokolov
FH10 Biomedical Topical Meeting (BIOMED) 2004
Konstantin Sokolov, Christina Robinson, Tom Collier, Rebecca Richards-Kortum, Michele Follen, and Rueben Lotan
MG1 Biomedical Topical Meeting (BIOMED) 2002
Rebecca Richards-Kortum, Jesse Aaron, Sonia Kumar, Preeti Rohatgi, Dawn Nida, Betsy Hsu, Tom Collier, Kung Bin Sung, Brette Luck, Michele Follen, Chen Liang, Michael Descour, and Konstantin Sokolov
SB1 Biomedical Topical Meeting (BIOMED) 2004